Undervirilization in XY newborns may hide a 5α-reductase deficiency: Report of three new SRD5A2 gene mutations

International Journal of Andrology

Volumn 33, Issue 6, 2010, Pages 841-847

  Maimoun, L ^a   Philibert, P ^a   Cammas, B ^a,b   Audran, F ^a   Pienkowski, C ^c   Kurtz, F ^d   Heinrich, C ^e   Cartigny, M ^f   Sultan, C ^a,b  

^a LAPEYRONIE HOSPITAL   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c HÔPITAL DES ENFANTS   (France)

^d Saint Avold Hospital   (France)

^e HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^f LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

5 reductase; Ambiguous genitalia; PAIS; XY newborn

Indexed keywords

ANDROGEN RECEPTOR; STEROID 5ALPHA REDUCTASE;

AMBIGUOUS GENITALIA; ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CASE REPORT; ENZYME DEFICIENCY; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HUMAN; KARYOTYPE 46,XY; MALE; MALE GENITAL SYSTEM DISEASE; NEWBORN; PARTIAL ANDROGEN INSENSITIVITY SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; UNDERVIRILIZATION;

EID: 78650474119     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2009.01036.x     Document Type: Article

References (38)

1. Adiyaman PB, Ocal G, Cetinkaya E, Akar N, Uysal A, Duman T et al. (2006) 5 alpha steroid reductase deficiency in Turkey. Pediatr Endocrinol Rev 3, 462-469.
2. Andersson S, Berman DM, Jenkins EP & Russell DW. (1991) Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 354, 159-161.
3. Bertelloni S, Scaramuzzo RT, Parrini D, Baldinotti F, Tumini S & Ghirri P. (2007) Early diagnosis of 5alpha-reductase deficiency in newborns. Sex Dev 1, 147-151.
4. Boudon C, Lobaccaro JM, Lumbroso S, Ogur G, Ocal G, Belon C & Sultan C. (1995a) A new deletion of the 5 alpha-reductase type 2 gene in a Turkish family with 5 alpha-reductase deficiency. Clin Endocrinol (Oxf) 43, 183-188.
5. Boudon C, Lumbroso S, Lobaccaro JM, Szarras-Czapnik M, Romer TE, Garandeau P, Montoya P & Sultan C. (1995b) Molecular study of the 5 alpha-reductase type 2 gene in three European families with 5 alpha-reductase deficiency. J Clin Endocrinol Metab 80, 2149-2153.
6. Cai LQ, Zhu YS, Katz MD, Herrera C, Baez J, DeFillo-Ricart M, Shackleton CH & Imperato-McGinley J. (1996) 5 alpha-reductase-2 gene mutations in the Dominican republic. J Clin Endocrinol Metab 81, 1730-1735.
7. Canto P, Vilchis F, Chavez B, Mutchinick O, Imperato-McGinley J, Perez-Palacios G, Ulloa-Aguirre A & Mendez JP. (1997) Mutations of the 5 alpha-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5 alpha-reductase-2 deficiency. Clin Endocrinol (Oxf) 46, 155-160.
8. Cicek MS, Conti DV, Curran A, Neville PJ, Paris PL, Casey G & Witte JS. (2004) Association of prostate cancer risk and aggressiveness to androgen pathway genes: Srd5a2, cyp17, and the AR. Prostate 59, 69-76.
9. Cohen-Kettenis PT. (2005) Gender change in 46, XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav 34, 399-410.
10. Fernandez-Cancio M, Rodo J, Andaluz P, Martinez de Osaba MJ, Rodriguez-Hierro F, Esteban C, Carrascosa A & Audi L. (2004) Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (g115d/r246w) in srd5a2 gene. Horm Res 62, 259-264.
11. Hackel C, Oliveira LE, Ferraz LF, Tonini MM, Silva DN, Toralles MB, Stuchi-Perez EG & Guerra-Junior G. (2005) New mutations, hotspots, and founder effects in Brazilian patients with steroid 5alpha-reductase deficiency type 2. J Mol Med 83, 569-576.
12. Hafez M, Mazen I, Ghali I, Sultan C & Lumbroso S. (2003) A new mutation of 5-alpha-reductase type 2 (a62e) in a large Egyptian kindred. Horm Res 59, 281-284.
13. Houk CP, Damiani D & Lee PA. (2005) Choice of gender in 5alpha-reductase deficiency: a moving target. J Pediatr Endocrinol Metab 18, 339-345.
14. Imperato-McGinley J, Gautier T, Pichardo M & Shackleton C. (1986) The diagnosis of 5 alpha-reductase deficiency in infancy. J Clin Endocrinol Metab 63, 1313-1318.
15. Lumbroso S, Lobaccaro JM, Georget V, Leger J, Poujol N, Terouanne B, Evain-Brion D, Czernichow P & Sultan C. (1996) A novel substitution (leu707arg) in exon 4 of the androgen receptor gene causes complete androgen resistance. J Pediatr Endocrinol Metab 81, 1984-1988.
16. Maes M, Sultan C, Zerhouni N, Rothwell SW & Migeon CJ. (1979) Role of testosterone binding to the androgen receptor in male sexual differentiation of patients with 5 alpha-reductase deficiency. J Steroid Biochem 11, 1385-1392.
17. Makridakis N, Ross RK, Pike MC, Chang L, Stanczyk FZ, Kolonel LN, Shi CY, Yu MC, Henderson BE & Reichardt JK. (1997) A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. Cancer Res 57, 1020-1022.
18. Makridakis NM, Di Salle E & Reichardt JK. (2000) Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II. Pharmacogenetics 10, 407-413.
19. Mazen I, Gad YZ, Hafez M, Sultan C & Lumbroso S. (2003a) Molecular analysis of 5alpha-reductase type 2 gene in eight unrelated Egyptian children with suspected 5alpha-reductase deficiency: prevalence of the g34r mutation. Clin Endocrinol (Oxf) 58, 627-631.
20. Mazen I, Hafez M, Mamdouh M, Sultan C & Lumbroso S. (2003b) A novel mutation of the 5alpha-reductase type 2 gene in two unrelated Egyptian children with ambiguous genitalia. J Pediatr Endocrinol Metab 16, 219-224.
21. Ng PC & Henicoff S. (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31, 3812-3814.
22. Nicoletti A, Baldazzi L, Balsamo A, Barp L, Pirazzoli P, Gennari M, Radetti G, Cacciari E & Cicognani A. (2005) Srd5a2 gene analysis in an Italian population of under-masculinized 46, XY subjects. Clin Endocrinol (Oxf) 63, 375-380.
23. Ntais C, Polycarpou A & Ioannidis JP. (2003) Srd5a2 gene polymorphisms and the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 12, 618-624.
24. Ocal G, Adiyaman P, Berberoglu M, Cetinkaya E, Akar N, Uysal A et al. (2002) Mutations of the 5alpha-steroid reductase type 2 gene in six Turkish patients from unrelated families and a large pedigree of an isolated Turkish village. J Pediatr Endocrinol Metab 15, 411-421.
25. Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM & French FS. (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16, 271-321.
26. Russell DW & Wilson JD. (1994) Steroid 5 alpha-reductase: two genes/two enzymes. Ann Rev Biochem 63, 25-61.
27. Sasaki G, Ogata T, Ishii T, Kosaki K, Sato S, Homma K, Takahashi T, Hasegawa T & Matsuo N. (2003) Micropenis and the 5alpha-reductase-2 (srd5a2) gene: mutation and v89l polymorphism analysis in 81 Japanese patients. J Clin Endocrinol Metab 88, 3431-3436.
28. Skordis N, Patsalis PC, Bacopoulou I, Sismani C, Sultan C & Lumbroso S. (2005) 5alpha-reductase 2 gene mutations in three unrelated patients of Greek cypriot origin: identification of an ancestral founder effect. J Pediatr Endocrinol Metab 18, 241-246.
29. Thai HT, Kalbasi M, Lagerstedt K, Frisen L, Kockum I & Nordenskjold A. (2005) The valine allele of the v89l polymorphism in the 5-alpha-reductase gene confers a reduced risk for hypospadias. J Clin Endocrinol Metab 90, 6695-6698.
30. Thigpen AE, Davis DL, Gautier T, Imperato-McGinley J & Russell DW. (1992a) Brief report: The molecular basis of steroid 5 alpha-reductase deficiency in a large Dominican kindred. N Engl J Med 327, 1216-1219.
31. Thigpen AE, Davis DL, Milatovich A, Mendonca BB, Imperato-McGinley J, Griffin JE, Francke U, Wilson JD & Russell DW. (1992b) Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 90, 799-809.
32. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD & Russell DW. (1993) Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest 92, 903-910.
33. Vilchis F, Mendez JP, Canto P, Lieberman E & Chavez B. (2000) Identification of missense mutations in the srd5a2 gene from patients with steroid 5alpha-reductase 2 deficiency. Clin Endocrinol (Oxf) 52, 383-387.
34. Wang Y, Li Q, Xu J, Liu Q, Wang W, Lin Y, Ma F, Chen T, Li S & Shen Y. (2004) Mutation analysis of five candidate genes in Chinese patients with hypospadias. Eur J Hum Genet 12, 706-712.
35. Wigley WC, Prihoda JS, Mowszowicz I, Mendonca BB, New MI, Wilson JD & Russell DW. (1994) Natural mutagenesis study of the human steroid 5 alpha-reductase 2 isozyme. Biochemistry 33, 1265-1270.
36. Wilson JD. (2001) Androgens, androgen receptors, and male gender role behavior. Horm Behav 40, 358-366.
37. Wilson JD, Griffin JE & Russell DW. (1993) Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 14, 577-593.
38. Zhu YS, Katz MD & Imperato-McGinley J. (1998) Natural potent androgens: lessons from human genetic models. Baillieres Clin Endocrinol Metab 12, 83-113.